Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis

Background: The addition of caplacizumab to immune thrombotic thrombocytopenia (iTTP) treatment options has led to a renewed interest in characterizing the epidemiology and risk factors for bleeding in iTTP. Limited data exist on the bleeding risk in iTTP due to systemic underreporting in earlier co...

Full description

Saved in:
Bibliographic Details
Main Authors: Amir A. Mahmoud, Mariam Mostafa, Ali Abdelhay, Mouhamed Yazan Abou-Ismail, Shruti Chaturvedi
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2475037924003492
Tags: Add Tag
No Tags, Be the first to tag this record!